# Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia

> **NCT06955858** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 60 (estimated)

## Conditions studied

- Hematopoietic Stem Cell Mobilization

## Interventions

- **DRUG:** Recombinant Human Thrombopoietin（rhTPO）

## Key facts

- **NCT ID:** NCT06955858
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955858, "Clinical Study of rhTPO in Hematopoietic Stem Cell Mobilization for Autologous Transplantation in Acute Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06955858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*